Spliced peptides: Novel candidates for effective influenza immunity?
Dr. Illing was the first to identify spliced peptides during a viral infection. This work involves an innovative new approach for identifying influenza-specific peptide antigens with implications for the development of vaccines against both seasonal and pandemic influenza strains. The Prize money will provide greater resources to expand understanding of how a viral antigen is recognized by the human immune system.
CONNECT WITH Patricia Therese Illing, Ph.D.